Karyopharm Therapeutics Inc. (KPTI): Capital Expenditures
$0
Year ended 2025-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $142.0K | n/a | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $118.0K | -44.3% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $212.0K | +46.2% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $145.0K | -29.6% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $206.0K | -91.3% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $2.36M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $62.0K | -11.4% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $70.0K | -95.1% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $1.42M | -50.0% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $2.83M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $57.0K | -52.9% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $121.0K | -67.8% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $376.0K | n/a | 2014-03-21, From 2011-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $0 | -100.0% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $925.6K | -43.0% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $1.91M | -48.4% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $317.0K | -81.4% |
| Liquidia Corp (LQDA) | 2025-12-31 | $4.34M | -12.4% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $13.41M | -27.1% |
| Xencor Inc (XNCR) | 2025-12-31 | $3.15M | -48.3% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $187.0K | n/a |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $229.0K | +69.6% |
Compare KPTI, ELTP, MGNX, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗